Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.650
-0.110 (-6.25%)
At close: Nov 17, 2026, 4:00 PM EST
1.640
-0.010 (-0.61%)
After-hours: Nov 17, 2026, 4:18 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $382.27 thousand as of November 17, 2026. It is the 50,544th most valuable company in the world and the 6,936th biggest in the United States. Its market cap has decreased by 95.69% in one year.
Market Cap
382.27K
Enterprise Value
-436.73K
1-Year Change
-95.69%
Global Rank
Country Rank
#6,936 United States
Category
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.39M to $382.27K, a decrease of -99.74%. That is a compound annual growth rate of -65.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 382.27K | -93.63% |
| Dec 31, 2025 | 6.00M | 86.42% |
| Dec 31, 2024 | 3.22M | -92.30% |
| Dec 21, 2023 | 41.83M | -72.00% |
| Dec 30, 2022 | 149.43M | 4.03% |
| Dec 31, 2021 | 143.64M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 908.01K |
| Oragenics | 893.37K |
| SciSparc | 814.66K |
| GeoVax Labs | 765.40K |
| Decoy Therapeutics | 590.32K |
| Scinai Immunotherapeutics | 546.84K |
| Lakewood-Amedex Biotherapeutics | 519.91K |
| Valion Bio | 469.54K |